Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial

This RCT (n=199) reports a similar reduction in seizure frequency with both the 10 and 20mg/kg/day doses of cannabidiol vs placebo (cannabidiol reduced seizure frequency by 48.7%, 45.7% respectively vs 26.9% with placebo).


JAMA Neurology